Severe Von Willebrand Disease (sVWD) Patient Registry

This is a patient registry for individuals with severe Von Willebrand Disease (sVWD), a bleeding disorder. The VWD Connect Foundation is creating a web-based database to collect information about people with sVWD, including their health history, symptoms, and lab results. This information will help researchers better understand sVWD and identify people who might be interested in future studies. You can join if you meet the diagnostic criteria for von Willebrand disease, specifically if your VWF antigen or activity is less than 20%, or less than 30% with significant bleeding symptoms that required hospitalization, surgery, blood transfusions, or a large drop in hemoglobin. The goal is to gather data for at least 5 years to support future research.

Study design
This is an observational study, meaning no interventions are given. It aims to enroll 400 participants.
What's involved
You will provide self-reported data or have registry personnel collect it. No clinical procedures, testing, or diagnostics are required for participation.
Compensation
Not stated in the trial record.
Follow-up
Outcomes are measured for at least 5 years, indicating a long-term follow-up for data collection.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05437536

The Severe Von Willebrand Disease (sVWD) Patient Registry

Recruiting
Not specifiedAll AgesObservational
VWD Connect Foundation
~400 participants
Updated 2026-04-22 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Outcomes are not applicable; this study is a patient registry.
Measured over At least 5 years
VWD - Von Willebrand's Disease
1 sites across 1 states
Florida1
  • Christopher Walsh, MD, PhD · PRINCIPAL_INVESTIGATOR · Mt. Sinai School of Medicine
  • Mrinal Gounder, MD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center
  • Christina Morgenthaler, MS, MBA · PRINCIPAL_INVESTIGATOR · VWD Connect Foundation

Opens a ready-to-send draft in your own email app — review before sending.

  • Outcomes are not applicable; this study is a patient registry.At least 5 years

    Statistical analyses will focus on simple characterization of the registry.